Diabetes Treatment Landscape Evolves Through Advancements in SGLT2 Inhibitor Drugs
SGLT2 Inhibitors Market for Diabetes Treatment Market reflects significant regional variation driven by healthcare infrastructure maturity, diabetes burden, regulatory frameworks, and insurance coverage policies. North America dominates the global market, accounting for the largest revenue share due to high per-capita healthcare spending, widespread physician awareness, and favorable...